Fox Chase Cancer Center News

Temple University Hospital and Fox Chase Researchers Investigate Relationship Between Fragmented Care and Social and Demographic Disparities

PHILADELPHIA (May 20, 2024) — Pancreatic cancer patients who received single modality neoadjuvant therapy experienced fragmented care, which is care at multiple centers, more often compared with those who received total neoadjuvant therapy, according to a study from researchers at Temple University Hospital and Fox Chase Cancer Center. The research was presented today at Digestive Disease Week (DDW).

VIEW STORY

Fox Chase’s Dr. Daniel Geynisman Named Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network

Daniel M. Geynisman, MD, Chief of the Division of Genitourinary Medical Oncology and an Associate Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, has been appointed Editor-in-Chief for JNCCN—Journal of the National Comprehensive Cancer Network. The National Comprehensive Cancer Network (NCCN) is a nonprofit alliance of leading cancer centers devoted to patient care, research, and education.

VIEW STORY